Combined upper-body resistance and aerobic exercise program for people treated for breast cancer
Official title: Investigation of the Effect of Combined Upper Extremity Resistance and Aerobic Exercise Training on Arm Exercise Capacity, Peripheral Muscle Strength and Arm Functionality in Patients With Breast Cancer
Run by Hacettepe University · NCT07070791 · Data updated 2026-11-12
This program will test whether a combined upper-body resistance and aerobic exercise routine helps people at least 15 months after breast cancer surgery improve arm function, strength, and symptoms.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Hacettepe University Academic / other |
| Locations | 1 site (Ankara, State) |
| Status | Recruiting |
| Started | July 8, 2025 |
| Main results expected | November 1, 2026 |
| Study ends | December 1, 2026 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07070791 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–80 years old who are physically inactive, at least 15 months after breast cancer surgery, and able to complete questionnaires and exercise testing are ideal candidates.
✕Probably not a fit
Patients with bilateral breast cancer, active infection, unstable hypertension or diabetes, symptomatic heart or lung disease, significant neurological or musculoskeletal conditions, or major cognitive impairment are unlikely to benefit or may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–80 who are physically inactive and at least 15 months after breast cancer surgery will be enrolled. Participants will follow a combined intervention of progressive upper-extremity resistance exercises (using elastic bands) plus upper-body aerobic training, with intensity increased over time. Outcomes will be measured before and after the intervention and likely include upper-limb strength, shoulder function, pain, signs of lymphedema, and quality of life. The protocol excludes those with bilateral disease, active infection, unstable cardiovascular or metabolic conditions, significant neurologic or musculoskeletal impairments, or other comorbidities that would prevent safe exercise.
Why it matters
Potential benefit: If successful, the program could improve arm strength and shoulder function, reduce pain and lymphedema-related symptoms, and enhance quality of life.
How similar studies have gone: Prior research of resistance and aerobic exercise in breast cancer survivors has shown improvements in strength, fatigue, and quality of life, although combined upper-extremity–focused programs are less commonly studied.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * To be between 18-80 years old, * Volunteering to participate in the research, * At least 15 months after breast cancer surgery, * No problems in reading and/or understanding the scales and being able to co-operate with the tests. * Physically inactive (60 minutes of structured exercise per week \<). Exclusion Criteria: * Presence of active infection, * Presence of bilateral breast cancer, * History of surgical, neurological or orthopaedic problems that may affect upper extremity functionality other than breast cancer surgery, * Having a neurological disease or other clinical diagnosis that may affect cognitive status, * Musculoskeletal and neurological disease that may affect exercise performance, symptomatic heart disease, previous lung surgery and malignant disease. * Presence of unstable hypertension or diabetes mellitus.
Where it's running
-
Hcettepe University
Ankara, State, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Ebru Calik Kutukcu, PhD — Hacettepe University
- Study coordinator: Ebru Calik Kutukcu, PhD
- Email: ebru.calik@hacettepe.edu.tr
- Phone: +903123051576
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Upper-arm aerobic exercise for arterial stiffness in women treated for breast cancer.
This trial will test whether an upper-extremity aerobic exercise program can reduce arterial stiffness in women aged 40–69 who are at least 15 months after breast cancer surgery and are currently physically inactive.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.